MedTech Breakthrough Recognizes STIM onTrack for Bone Growth Therapy as Best Patient Engagement Mobile App
04 Maio 2023 - 8:00AM
Business Wire
Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and
orthopedics company, today announced that the STIM onTrack™ mobile
app was recognized as the “Best Patient Engagement Mobile App” by
MedTech Breakthrough, an independent market intelligence
organization that recognizes the top companies, technologies and
products in the global health and medical technology market.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230504005188/en/
The STIM onTrack mobile app empowers
patients to track the daily use of their bone growth therapy device
to help them stay on schedule with their treatments. The app
enables the sharing of treatment data and patient reported outcome
measures with physicians to assist in monitoring progress and
overall recovery status. (Photo: Business Wire)
The STIM onTrack mobile app works with Orthofix CervicalStim™,
SpinalStim™, and PhysioStim™ Bone Growth Therapy devices. Designed
for use with smartphones and other mobile devices, the app provides
tools such as a daily treatment reminder to help patients adhere to
their prescriptions and improve their clinical outcomes.
“Orthofix was the first to bring to market a patient mobile app
for bone growth stimulation devices,” said Kevin Kenny, President
of Orthofix Global Spine. “We are pleased to accept this award from
MedTech Breakthrough. Our dedicated team works hard every day to
develop patient-focused technologies like the STIM onTrack app to
deliver on our commitment to improving patients’ lives and
delivering innovative, quality-driven solutions.”
“The STIM onTrack mobile app redefines the recovery experience
for patients,” said Jason Shallenberger, Vice President of Bone
Growth Therapy U.S. Sales and Marketing. “The purpose of the app is
to empower patients to take an active role in their recovery. We
are very proud of the STIM onTrack app and the work that went into
developing this tool to assist patients in their recovery
efforts.”
Patients can track the daily use of their bone growth therapy
device to help them stay on schedule with their treatments. The app
enables the sharing of treatment data and patient reported outcome
measures with physicians to assist in monitoring progress and
overall recovery status. Through the app, patients can also connect
with the Orthofix Patient Care team to help address questions about
their treatment regimen. The app is free and supported by iOS and
Android devices. This is the second award for the STIM onTrack
mobile app. The first generation of the app was recognized as the
winner of the 2017 Spine Technology Award from Orthopedics This
Week.
CervicalStim, SpinalStim and PhysioStim bone growth stimulators
are approved by the FDA and provide patients with a safe and
effective nonsurgical treatment to improve nonunion fractures and
spinal fusion healing. These devices use a pulsed electromagnetic
field (PEMF) to introduce a low-level electrical field at the
nonunion fracture or spinal fusion site which stimulates bone
healing. To learn more about the STIM onTrack mobile app and bone
growth therapy, please visit BoneGrowthTherapy.com.
About Orthofix
The newly merged Orthofix-SeaSpine organization is a leading
global spine and orthopedics company with a comprehensive portfolio
of biologics, innovative spinal hardware, bone growth therapies,
specialized orthopedic solutions and a leading surgical navigation
system. Its products are distributed in approximately 68 countries
worldwide.
The Company is headquartered in Lewisville, Texas and has
primary offices in Carlsbad, CA, with a focus on spine and
biologics product innovation and surgeon education, and Verona,
Italy, with an emphasis on product innovation, production, and
medical education for orthopedics. The combined company’s global
R&D, commercial and manufacturing footprint also includes
facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale,
CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany,
Paris, France and São Paulo, Brazil. For more information, please
visit www.Orthofix.com.
About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and
recognition platform for global technology innovation and
leadership, the MedTech Breakthrough Awards program is devoted to
honoring excellence and innovation in medical and health technology
companies, products, services and people. The MedTech Breakthrough
Awards provide a platform for public recognition around the
achievements of breakthrough healthcare and medical companies and
products in categories that include Patient Experience and
Engagement, Health and Fitness, Medical Devices, Clinical
Administration, Connected Healthcare, Medical Data, Healthcare
Cybersecurity and more. For more information, visit
MedTechBreakthrough.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230504005188/en/
Alexa Huerta Investor Relations Tel 214 937 3190 Denise Landry
Media Relations Tel 214 937 2529
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Orthofix Medical (NASDAQ:OFIX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024